HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasodilator efficiency of endogenous prostanoids, Ca²⁺-activated K⁺ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension.

Abstract
Hypertension is associated with the imbalance of vasoconstrictor and vasodilator systems. Vasodilation is usually evaluated in isolated blood vessels, but except for nitric oxide (NO), relatively little attention is given to the in vivo efficiency of particular vasodilator mechanisms. The aim of our study was to evaluate the contribution of endogenous vasodilator prostanoids, Ca(2+)-activated K(+) channels and NO to blood pressure (BP) maintenance in rats with three different forms of experimental hypertension. Both principal vasopressor systems (the renin-angiotensin system and the sympathetic nervous system) were blocked by captopril and pentolinium in conscious spontaneously hypertensive rats (SHRs), Dahl salt-hypertensive (DS-HS) rats and rats with NO-deficient hypertension, as well as in their normotensive controls. Thereafter, we monitored BP changes in rats subjected to either a sequential or an isolated blockade of prostanoid synthesis by the non-selective cyclooxygenase inhibitor, indomethacin, of Ca(2+)-activated K(+) channels by tetraethylammonium and of NO formation by N(G)-nitro-L-arginine methyl ester. All three forms of experimental hypertension were characterized by augmented sympathetic vasoconstriction. The vasodilatation exerted by endogenous prostanoids and Ca(2+)-activated K(+) channels was enhanced in all forms of hypertension, almost proportionally to BP elevation. On the contrary, NO-dependent vasodilatation was not enhanced in any form of experimental hypertension, and there was a severe relative NO deficiency in both, SHRs and DS-HS rats. In conclusion, our data suggested that there is a compensatory activation of vasodilator prostanoids and Ca(2+)-activated K(+) channels in rats with experimental hypertension, whereas NO-dependent vasodilatation is not augmented. Thus, the overall activity of vasodilator systems failed to compensate for augmented sympathetic vasoconstriction in hypertensive animals.
AuthorsMichal Behuliak, Mária Pintérová, Jaroslav Kuneš, Josef Zicha
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 34 Issue 8 Pg. 968-75 (Aug 2011) ISSN: 1348-4214 [Electronic] England
PMID21818109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclooxygenase Inhibitors
  • Potassium Channels, Calcium-Activated
  • Prostaglandins
  • Vasoconstrictor Agents
  • Nitric Oxide
  • Captopril
  • Indomethacin
Topics
  • Animals
  • Blood Pressure (drug effects, physiology)
  • Captopril (pharmacology)
  • Cyclooxygenase Inhibitors (pharmacology)
  • Hypertension (etiology, metabolism, physiopathology)
  • Indomethacin (pharmacology)
  • Nitric Oxide (metabolism)
  • Potassium Channels, Calcium-Activated (metabolism)
  • Prostaglandins (metabolism)
  • Rats
  • Rats, Inbred Dahl
  • Rats, Inbred SHR
  • Vasoconstriction (drug effects, physiology)
  • Vasoconstrictor Agents (pharmacology)
  • Vasodilation (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: